One well documented family of enzymes responsible for the proteolytic processes that occur in the extracellular matrix is the soluble and membrane-associated matrix metalloproteinases. Here we present the first theoretical model of the biochemical network describing the proteolysis of collagen I by matrix metalloproteinases 2 (MMP2) and membrane type 1 matrix metalloproteinases (MT1-MMP) in the presence of the tissue inhibitor of metalloproteinases 2 (TIMP2) in a bulk, cellfree, well stirred environment. The model can serve as a tool for describing quantitatively the activation of the MMP2 proenzyme (pro-MMP2), the ectodomain shedding of MT1-MMP, and the collagenolysis arising from both of the enzymes. We show that pro-MMP2 activation, a process that involves a trimer formation of the proenzyme with TIMP2 and MT1-MMP, is suppressed at high inhibitor levels and paradoxically attains maximum only at intermediate TIMP2 concentrations. We also calculate the conditions for which pro-MMP2 activation is maximal. Furthermore we demonstrate that the ectodomain shedding of MT1-MMP can serve as a mechanism controlling the MT1-MMP availability and therefore the pro-MMP2 activation. Finally the proteolytic synergism of MMP2 and MT1-MMP is introduced and described quantitatively. The model provides us a tool to determine the conditions under which the synergism is optimized. Our approach is the first step toward a more complete description of the proteolytic processes that occur in the extracellular matrix and include a wider spectrum of enzymes and substrates as well as naturally occurring or artificial inhibitors.
One well documented family of enzymes responsible for the proteolytic processes that occur in the extracellular matrix is the soluble and membrane-associated matrix metalloproteinases. Here we present the first theoretical model of the biochemical network describing the proteolysis of collagen I by matrix metalloproteinases 2 (MMP2) and membrane type 1 matrix metalloproteinases (MT1-MMP) in the presence of the tissue inhibitor of metalloproteinases 2 (TIMP2) in a bulk, cellfree, well stirred environment. The model can serve as a tool for describing quantitatively the activation of the MMP2 proenzyme (pro-MMP2), the ectodomain shedding of MT1-MMP, and the collagenolysis arising from both of the enzymes. We show that pro-MMP2 activation, a process that involves a trimer formation of the proenzyme with TIMP2 and MT1-MMP, is suppressed at high inhibitor levels and paradoxically attains maximum only at intermediate TIMP2 concentrations. We also calculate the conditions for which pro-MMP2 activation is maximal. Furthermore we demonstrate that the ectodomain shedding of MT1-MMP can serve as a mechanism controlling the MT1-MMP availability and therefore the pro-MMP2 activation. Finally the proteolytic synergism of MMP2 and MT1-MMP is introduced and described quantitatively. The model provides us a tool to determine the conditions under which the synergism is optimized. Our approach is the first step toward a more complete description of the proteolytic processes that occur in the extracellular matrix and include a wider spectrum of enzymes and substrates as well as naturally occurring or artificial inhibitors.
A major mode of angiogenesis is capillary sprouting that involves the formation and stabilization of a sprouting bud built from a pool of proliferating endothelial cells near the basal lamina. The rate-determining step for this process is the disengagement of the natural barriers that restrict the unconfined migration of the proliferating cells into the neovascularized tissue (1) (2) (3) . These barriers are comprised of the structural elements of the basement membrane and the extracellular matrix (ECM) 1 including the different types of collagens, either fibrillar (collagens I and II) or network-forming (collagen IV), elastic fibers, proteoglycans, and glycosaminoglycans as well as different glycoproteins, the biochemical "glue" of all of these components.
A prerequisite for the migration of endothelial cells through the ECM is the initiation, at the cell surface, of a biochemical pathway responsible for the proteolytic degradation of all these structural barriers (4) . Growth factor stimulation leads to the secretion of ECM-digesting enzymes, proteases, from endothelial cells, stromal cells, or both (3) and in the case of tumor angiogenesis, from the tumor cells (5) . The production of proteases by these cells can lead to profound changes in the morphology of the surrounding ECM that will finally attenuate the restrictive structural barriers and allow the proliferating population of endothelial cells to migrate into the avascular tissue. Furthermore it can lead to the release of growth factors from the ECM, specifically of vascular endothelial growth factor and basic fibroblast growth factor (FGF-2), for which theoretical models are emerging (6, 7) .
One well studied class of these enzymes is the soluble and membrane-associated matrix metalloproteinases (MMPs) (1, 8, 9) . During angiogenesis and in response to various angiogenic factors such as vascular endothelial growth factor, MMPs are up-regulated at the level of expression as well as relocalized at the fronts of the migrating cells where they initiate the proteolytic pathway. Although these proteins have been thoroughly examined experimentally, there is yet no integrative, quantitative description of the biochemical mechanisms responsible for the extracellular matrix degradation.
Here we examine theoretically the biochemical network responsible for the degradation of collagen I by the membrane type metalloproteinase MT1-MMP, which under physiologic conditions resides at the cell surface, and by matrix metalloproteinase MMP2 in the presence of the tissue inhibitor of metalloproteinase TIMP2. The reactions of the biochemical network are modeled in bulk, "well stirred" solution in a cellfree system. This description follows a variety of experimental approaches where free MMP2s, the MT1-MMPs bound on membrane fragments, or the proteins devoid of their transmembrane domain that restricts them on the cell surface (⌬TM-MT1-MMP) interact with their substrates or inhibitors in bulk conditions.
Under physiologic conditions MMP2 is secreted mainly by endothelial cells in its inactive form, or zymogen, pro-MMP2, and it has been established that its activation occurs mostly via a mechanism involving complex formation that consists of the zymogen, MT1-MMP, and TIMP2 in 1:1:1 stoichiometry. The * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
proposed model can serve as a tool for quantifying the activation of the MMP2 zymogen as a function of the MT1-MMP and TIMP2 concentrations. In agreement with a previously proposed experiment-based hypothesis regarding the effects of TIMP2 on the pro-MMP2 activation, we demonstrate that low TIMP2 concentration is not able to initiate the activation of pro-MMP2, while high concentrations inhibit the zymogen processing. We also predict concentration ratios where the activation occurs at higher reaction rates. The ectodomain shedding of the membrane-bound MT1-MMP, a process where the catalytic part of MT1-MMP (MT1 cat ) is shed from the rest of the protein creating an 18-kDa fragment, is also incorporated in our description. We show that the ectodomain shedding regulates the "functional" MT1-MMP population dynamics thus imposing an extra regulatory mechanism for the pro-MMP2 activation. Once activated, MMP2 can bind to and be inhibited by TIMP2. In our model we test the hypothesis that MMP2 can form either a single or two-isoform (an intermediate and a final) complex with TIMP2, and the dynamics of the two species are predicted. In the latter case, we show that the intermediate isoform is a low concentration, extremely transient species that makes it hard to be experimentally observed and suggest possible conditions where the specific molecule can be detected. The enzyme that is not inhibited by TIMP2 can bind and degrade collagen. Our model delineates this phenomenon by considering the effect of the initial ratios of the protease/inhibitor concentrations on the progress of the collagenolytic activity of the enzyme. We show that the two MMP2⅐TIMP2 isoform approach describes a stronger inhibitory effect, inducing almost a biphasic (all or none) response on the MMP2 enzymatic potential depending on the enzyme/inhibitor initial concentrations ratios. Finally we merge all the aforementioned modules to gain quantitative insight into the MMP2/MT1-MMP synergism on collagen I degradation. This is the first biochemical reaction kinetic model developed to study the proteolytic properties of the MMP protein family, and it is the first step toward a more detailed description that will account for the multiple enzymes and substrates of the proteolytic processes in the extracellular matrix.
MATERIALS AND METHODS
Model Computations-The system of ordinary nonlinear differential equations describing the time evolution of the various species concentrations, as shown schematically in Fig. 1 , briefly presented in the on-line supplement and discussed below, was numerically solved using Mathworks Matlab® software. A solver for stiff problems, ode23s, was chosen for most of the cases. All the calculations were performed in double precision, and for the time integration either a subsecond time step was chosen or the solver used adjustable time steps in accordance with a specified accuracy (10 Ϫ13 -10 Ϫ14 M). The model was solved for varying initial concentrations usually similar to those used in many of the reported in vitro experiments. The rate constants for each of the reactions included in the biochemical network are summarized in Table  I and are discussed below under "Results and Discussion."
RESULTS AND DISCUSSION
Model Formulation-Based on the extensive analysis of published experimental data, we represent the biochemical network of collagen I proteolysis induced by the membrane type proteinase MT1-MMP and the free diffusible species MMP2. The latter is activated by forming complexes with MT1-MMP and the inhibitor TIMP2. The reaction scheme is summarized in Fig. 1 .
Under physiologic conditions, the MT1-MMP is a key enzyme for the ECM invasive capacity of the cells (10, 11) . Its activation occurs mostly intracellularly, and it can degrade collagen or it can bind to TIMP2, which is either secreted by the same or by neighboring cells, forming a dimer, MT1-MMP⅐TIMP2. This dimer has the potential of inducing activation of pro-MMP2. Murphy and co-workers (12) have used C-terminal domain mutants to define the role of interactions of pro-MMP2 and MT1-MMP in the binding of TIMP2 and in the activation of the MMP2 zymogen. Soluble constructs of MT1-MMP were used to demonstrate that binding with TIMP2 occurs primarily through N-terminal domain interactions, leaving the C-terminal domain free for interactions with the zymogen. The kinetics of the inhibitory association for MT1-MMP is well studied, and the rate constants have been reported (12) (13) (14) (15) . Once pro-MMP2 is "locked" onto the MT1-MMP⅐TIMP2 complex a second, TIMP2-free, MT1-MMP initiates the activation of the zymogen, which later matures into a fully functional protease via an autolytic mechanism (16) .
The membrane metalloproteinases, which do not participate in the activation events, can either proteolytically cleave themselves, secreting their catalytic domain, MT1 cat (17) , or can bind to collagen and denature it (18) . Release of the extracellular portion of type I transmembrane proteins, referred to as ectodomain shedding, has been established as a major regulatory mechanism to control the activity of a variety of membrane-bound proteins on the cell surface. Previous studies by Fridman and co-workers (19) have shown that the active MT1-MMP is autocatalytically processed by a second order reaction on the cell surface to an inactive membrane-tethered ϳ44-kDa species lacking the entire catalytic domain. Although Toth et al. (17) have shown the existence of two distinct shedding pathways, an autocatalytic and a non-autocatalytic pathway, in the present approach we consider only the former because a detailed mechanism for the latter has not yet been characterized.
Once the MMP2 zymogen is activated by MT1-MMP at the cell surface, it can diffuse into the collagen matrix and initiate proteolytic events leading to the fibril degradation (Fig. 1) . It can also be inhibited after binding to the free diffusing TIMP2. In our TIMP2 and MMP2 binding analysis, we adopt and compare two approaches: a classic single step inhibitory mechanism suggested by Olson et al. (20) and a scheme introduced by Murphy and co-workers (21) where the two species form two distinct isoforms, MMP2⅐TIMP2 and MMP2⅐TIMP2*. The MMP2-induced collagenolytic process is considered a simple catalytic reaction where the enzyme initially forms a dimer with collagen I, MMP2⅐collagen I, and it is this dimer that upon dissociation yields the denatured product. In our analysis we adopt the kinetics from several previous investigations for collagen I matrices (21, 22) .
Pro-MMP2 Activation-The present theoretical model provides us a quantitative tool for investigating the effects of the initial pro-MMP2, TIMP2, and MT1-MMP concentrations on the proenzyme activation kinetics. The kinetics will depend on the concentrations of the two molecules involved in the activation mechanism: the free MT1-MMP and the trimer MT1-MMP⅐TIMP2⅐pro-MMP2 (Fig. 1) . Thus a detailed description of the dynamics of the two species can provide insight into the activation kinetics.
By considering MT1-MMPs (in their ⌬TM-MT1-MMP form) as molecules in bulk solution with TIMP2 and pro-MMP2 and by varying the initial conditions of the proenzyme, the inhibitor TIMP2, and the activating enzyme MT1-MMP, we can perform numerical experiments studying the formation of the different complexes, such as the MT1-MMP⅐TIMP2 or the MT1-MMP⅐TIMP2⅐pro-MMP2, as well as calculate the availability of free MT1-MMP (Fig. 2, A and B) . For the calculations an initial concentration of 50 nM pro-MMP2 is used, while the TIMP2 varies from 0 to 200 nM, and MT1-MMP varies from 0 to 100 nM. Looking at the particular set of data and taking into consideration the dependence of the activation mechanism on the concentration of the free MT1-MMP ( Fig. 2A ) and the triple complex MT1-MMP⅐TIMP2⅐pro-MMP2 (Fig. 2B) , one can test the existence of pairs of initial MT1-MMP and TIMP2 concentrations that may yield proenzyme activation, expressed quantitatively as the amount of initial pro-MMP2 that is transformed into the active protease. At low inhibitor concentrations (e.g. for 4 nM TIMP2) the free MT1-MMPs are predominant. At these conditions, however, the formed MT1-MMP⅐TIMP2⅐pro-MMP2 trimer levels are minimal as there is no TIMP2 available for the triple complex formation. At high inhibitor concentrations (e.g. 200 nM TIMP2) the amount of the free MT1-MMP drops to almost zero levels. The entire amount of the enzyme is used up either by forming dimers with the inhibitor or trimers with TIMP2 and pro-MMP2. It is the latter complexes that are waiting to initiate the activation of the proenzyme, a process that for these conditions is improbable because there is no free "activator." Thus pro-MMP2 activation is likely to initiate at the intermediate inhibitor levels. By taking into consideration the actual kinetics of the proenzyme activation and not only the dynamics of isoform formation, we can test the existence of such conditions that can yield pro-MMP2 activation.
The kinetics of the proenzyme formation can be investigated by incorporating an activation step in the studied mechanism. As already mentioned, the physiologic activation of the pro-MMP2 occurs via an already activated protease, usually an MT1-MMP, which initiates cleavage of its propeptide domain. This process is usually completed through an intramolecular, autocatalytic maturation of the proenzyme into a fully functional moiety (23) . The activation step is modeled as an enzymatic reaction where the trimer MT1-MMP⅐TIMP2⅐pro-MMP2, which can be considered as a classic "substrate," forms a complex with the activating enzyme MT1-MMP.
Although, so far, no rate constants for this process have been reported, one can utilize the results determining the zymogen activation by measuring its ability to cleave fluorescently labeled substrates under conditions where its activation occurs either by cleaved MT1-MMPs (⌬TM-MT1-MMPs) or by cell-derived MT1-MMPs containing membranes in bulk solution with TIMP2 and pro-MMP2 (12, 24, 25) and thus calculate a set of kinetic constants. In the bulk pro-MMP2 activation experiments, for example those reported by English et al. (25) , the direct activation of the proenzyme by free ⌬TM-MT1-MMP is measured. Assuming activation of 0.9 M pro-MMP2 by 0.09 M soluble protease and using rate constants
Ϫ3 s Ϫ1 , and k MMP2 act ϭ 2 ϫ 10 Ϫ2 s Ϫ1 , we can reproduce the reported experimental results (Fig. 2C ). In the kinetic mechanism, no separate MMP2 autolytic step is considered, and the maturation dynamics of the enzyme is incorporated in the "activation step." Interestingly the calculated dissociation rate, k MT1⅐TIMP2,pro-MMP2 off ϭ 0.9 ϫ 10Ϫ3 10 Ϫ3 s Ϫ1 , is low, implying that once pro-MMP2 encounters the TIMP2-free MT1-MMP it will get activated; a non-activatory dissociation of this complex is extremely slow/nearly absent. Also by considering a steady state for the pro-MMP2⅐MT1-MMP intermediate complex and by using k MMP2 act,eff ϭ 2.8 ϫ 10 Ϫ3 M Ϫ1 s Ϫ1 the experimental results are also reproduced especially at time scales greater than 1 h.
Considering that the pro-MMP2 has already formed a trimer with MT1-MMP and TIMP2 and adopting the calculated kinetics for free pro-MMP2 activation as shown in the reaction scheme describing the formation of the various isoforms (Fig.  1) , we can calculate the amount of the active enzyme formed. The assumption that the free and a trimer-associated pro-MMP2 have similar activation kinetics is valid in the current context. The trimer-associated proenzyme resides at the outer part of the complex, thus any steric interruptions with the other complex-participating species are unlikely; in addition, in a well stirred environment of the experiments under consideration the diffusion limitations are negligible.
The pro-MMP2 activation calculations are performed for the ranges of initial concentrations of MT1-MMP and TIMP2 used above, and the activation profiles are shown in Fig. 2D . The model predicts pro-MMP2 activation maxima for the set of initial concentrations of MT1-MMP and TIMP2. This maximum activation occurs neither at high free MT1-MMP concentrations where the MT1-MMP⅐TIMP2⅐pro-MMP2 species are sparse nor at high MT1-MMP⅐TIMP2⅐pro-MMP2 concentrations where there are no free MT1-MMPs. All these maxima lie approximately on a straight line described by the equation [TIMP2] ϭ 0.64 ϫ [MT1-MMP] Ϫ 0.74 (nM). Consequently, by considering the aforementioned activation mechanism, maximum pro-MMP2 activation occurs at an initial MT1-MMP/ TIMP2 concentration ratio of 3:2.
MT1-MMP Ectodomain Shedding-Adopting an approach similar to the one used for studying the pro-MMP2 activation and by using our theoretical model we can gain an insight into the dynamics of ectodomain shedding of two TIMP2-free MT1-MMPs to result in the diffusible MT1 cat . This 18-kDa species does not cleave collagen and does not bind to TIMP2 (17) . By considering the intermolecular interactions in solution of free MT1-MMPs lacking their transmembrane region, we can study quantitatively the dynamics of the ectodomain shedding after assigning kinetic constants to the process. These constants describe the kinetics of the formation of a single MT1 cat once two TIMP2-free MT1-MMPs encounter each other and one autocatalytically cleaves the other. In the absence of any reported activation kinetics, we adopt the kinetics used in the previous section where the activation constant corresponds to an encounter of two MT1-MMPs, one of them complexed with pro-MMP2, to yield an activated enzyme, MMP2. In the case of ectodomain shedding, the effective "activation" constant is equal to k MT1 cat shed,eff ϭ 2.8 ϫ 10 Ϫ3 M Ϫ1 s Ϫ1 , similar to the effective constant used in the case of pro-MMP2 activation. This assumption may be considered valid as both of the above constants describe the probability of an encounter of two MT1-MMPs that autolytically yields an active species (Fig. 1) .
The numerical results can help us understand the functionality of MT1 cat shedding in an environment where multiple processes, such as pro-MMP2 activation or collagen degradation, occur in parallel. An important result of the model is the indication of a TIMP2-induced regulatory mechanism during ectodomain shedding. The inhibitor TIMP2 can trigger a protective mechanism for MT1-MMPs. Once bound to the membrane type protease it shifts the reaction equilibrium from the ectodomain shedding toward the pro-MMP2 activation path. This pathway antagonism, which is initiated by TIMP2, can be visualized by plotting the molecular balances of the activated MMP2 species and shed MT1-MMPs for different TIMP2 initial concentrations. At low initial MT1-MMP and inhibitor levels the dominating species, after 12 h from the initiation of the biochemical reactions, is the free MT1-MMP (Fig. 3A) . By in- creasing the MT1-MMP initial concentration the ectodomain shedding mechanism is initiated and yields the MT1 cat (Fig. 3B ) as well as a coordinate reduction in the amount of free MT1-MMP. An increase of TIMP2 concentration initiates the inhibitory mechanism of the surface proteases and shifts the balance toward the MT1-MMP⅐TIMP2⅐pro-MMP2 complex, the first step toward pro-MMP2 activation (Fig. 3C) . However, at higher initial MT1-MMP levels the ectodomain shedding is predominant over the triple complex formation.
As already mentioned, the initiation of the ectodomain shedding mechanism, especially at high TIMP2 concentration levels, yields a decrease in the amount of the triple complex formation, the first step toward pro-MMP2 activation. Also ectodomain shedding induces a decrease in the amount of TIMP2-free MT1-MMP, the activator of the proenzyme. This decrease, as already shown, is prominent especially at high protease levels where the shedding is enhanced. By considering the biochemical network of pro-MMP2 activation, the decrease of these two parameters will reflect a reduction in the amount of MMP2 that gets activated especially at higher MT1-MMP concentration levels where the shedding mechanism is predominant. But it is not only the availability of the MT1-MMP, either free or complexed, that regulates the activation process; the amount of the free TIMP2, as part of the triple complex, affects the above mechanism as well (Fig. 3D) .
So far in our description we considered the 18-kDa shed part of MT1-MMP that cannot bind TIMP2. Toth et al. (17) have shown that this fragment is the final product of a series of transformations of an initially shed 21-kDa species. This 21-kDa intermediate fragment is extremely unstable, and it transiently matures into the 18-kDa fragment. Recombinant expression of the 21-kDa species (17) has revealed that it possesses proteolytic properties and it can bind to TIMP2.
To gain insight into the significance of such a product, in case it exists under physiologic conditions, we examined the effects of the ability of this fragment to bind TIMP2 on the MT1-MMP⅐TIMP2⅐pro-MMP2 complex formation and downstream on pro-MMP2 activation. The calculations show that the 21-kDa species absorbs part of the total TIMP2 (3-4%) thus acting as an extra "sink" for the inhibitor. Furthermore the presence of this fragment induces a slight decrease of the activated MMP2 (1-2%) suggesting that if it exists it can act as a TIMP2 "molecular decoy" and contribute to the fine tuning of the inhibitor allocation; however, the effects are very small.
MT1-MMP-induced Collagenolysis-
The MT1-MMPs that do not participate in the pro-MMP2 activation or ectodomain shedding are extremely potent proteolytic enzymes. The degrading potential of MT1-MMP for various types of collagens is already established (26, 27) . The surface-bound enzyme can cleave type I, II, and III collagens under non-denaturing conditions (at temperatures below 35°C) into the 3 ⁄4 and 1 ⁄4 fiber length fragments. By incubating the various types of collagens with different initial concentrations of the proteases, it has also been shown that MT1-MMPs digest type I collagen with 6.5-fold higher proteolytic ability than type II and 4-fold higher proteolytic ability than type III.
In our description we utilize the MT1-MMP enzymatic constants provided by Ohuchi et al. (18) . The model can be used effectively in explaining the various aspects of MT1-MMP behavior as dictated, most of the time, by its surrounding envi-
FIG. 3. The behavior of MT1-MMP depends on the levels of TIMP2.
A, the effect of ectodomain shedding on the free and functional MT1-MMPs is studied for TIMP2 varying from 0 to 20 nM, MT1-MMP from 0 to 50 nM, and 100 nM initial pro-MMP2. At low initial MT1-MMP and TIMP2 concentration levels, the dominating species after 12 h is the MT1-MMPs. B, at increasing MT1-MMP levels, the ectodomain shedding mechanism is initiated and yields the MT1 cat . C, an increase of TIMP2 concentration initiates the inhibitory mechanism of the surface proteases and shifts the balance toward the MT1-MMP⅐TIMP2⅐pro-MMP2 complex, the first step toward pro-MMP2 activation. The results are shown as percentage of the initial MT1-MMP concentration. D, the activation of 50 nM pro-MMP2, for TIMP2 varying from 0 to 20 nM, and for MT1-MMP from 0 to 50 nM after 12 h in the absence and presence of ectodomain shedding. At high levels of MT1-MMPs and TIMP2 the pro-MMP2 activation is dominant. In the case where ectodomain shedding occurs in parallel, the pro-MMP2 activation is suppressed as there is less MT1-MMP available for the activation event. For D, the activation is characterized as a percentage of the activated enzyme over the initial pro-MMP2 levels. ronment, the collagen fibers, and TIMP2. On the one hand, we can describe quantitatively and qualitatively the various steps of the collagen I proteolysis by the MT1-MMP. On the other hand, the integrative, quantitative description of the enzymatic properties can be proven useful in gaining insight into the effect of TIMP2 on the redistribution of the various parallel tasks of MT1-MMP including the collagen proteolysis, the ectodomain shedding, and the pro-MMP2 activation. First, however, for the sake of a more complete description of the biochemical events that initiate from both of the studied proteases, it will be useful to introduce and study the proteolytic and inhibitory events arising from MMP2. Later, by considering the complete biochemical network, the parallel processes arising from MT1-MMPs will be analyzed.
MMP2⅐TIMP2 Isomerization-Once the pro-MMP2 zymogen is activated it can bind to TIMP2 and be inhibited or it can degrade the surrounding collagen. To study the MMP2 inhibition kinetics by TIMP2, in the present model we adopt two schemes: a single step inhibitory mechanism introduced by Olson et al. (20) with measured K i ϭ 7.2 nM and a two-isoform scheme suggested by Hutton et al. (21) . In the latter scheme, the inhibition of the MMP2 activity occurs as a two-step process where TIMP2 initially forms a "loose" complex with MMP2, MMP2⅐TIMP2, with reported K i ϭ 1.07 M (21), that later "matures" into a second isoform, MMP2⅐TIMP2*. This process of maturation, represented by the k iso kinetic constant, is attributed to conformational changes during the complex stabilization step (21) . In the case of the two-isoform approach, the model can be used to gain insight into the nature of the intermediate MMP2⅐TIMP2 complex, a species that differentiates the two models and is responsible for the order of magnitude difference in the inhibition equilibrium constants. For different initial enzyme and inhibitor concentrations the model can be used to calculate the concentrations of the two isoforms. For initial MMP2 concentrations ranging from 10 to 30 pM and for a constant MMP2/TIMP2 initial concentration ratio of 1:10, values similar to those used in the corresponding experiment (21) , the dynamics of the two-isoform profiles can be predicted (Fig. 4) . The final MMP2⅐TIMP2* isoform formation reaches a steady state within several hours depending on the initial concentrations of the species (Fig. 4B) . It is important to note the transient behavior and low concentration profile of the intermediate species, a few femtomolar, which makes it difficult to be measured experimentally (Fig. 4A) . However, for MMP2 concentrations in the range of 1-10 nM and an MMP2/ TIMP2 ratio of 1:1, greater than those used by Hutton et al. (21) , the model predicts higher, a few picomolar, and possibly measurable intermediate isoform levels (data not shown).
MMP2⅐Collagen I Complexes-The ability of MMP2 to degrade fibrillar collagen I is well documented (22) . In the current approach, we consider that MMP2 can be absorbed and cleave fibrillar collagen with the measured K m ϭ 8.5 M and k cat ϭ 16.2 h Ϫ1 (22) . The experimental results describing the cleavage of rat tendon and bovine skin type I collagen by MMP2 (22) can be fully reproduced using our theoretical approach. The calculated adsorption constant of MMP2 onto collagen is k on ϭ 2.6 ϫ 10 3 M Ϫ1 s Ϫ1 . Accurate reproduction of the proteolysis profiles, using the specific constants (Fig. 5A) , suggests that the collagen binding regions of the pro-MMP2 and the activated enzyme bear similarity.
The Effects of TIMP2 on MMP2-induced Collagenolysis-By combining the two aforementioned modules, the inhibition of MMP2 by TIMP2 and the proteolytic activity of MMP2, we are able to develop a detailed quantitative description of the effect of the inhibitor on the collagenolytic potential of the enzyme. The model provides us a tool to delineate the effect of TIMP2 on the enzyme adsorption on collagen fibers. By obliterating the collagenolytic activity of MMP2 in a collagen I-free environment and for different initial MMP2/TIMP2 ratios, we can predict the percentage of the enzyme that is absorbed onto the inhibitor at that steady state condition reached within 12 h for both the single or double isoform models (Fig. 5B) . The twoisoform approach describes a stronger inhibitory effect than that initiated by the single isoform. This inhibitory description has biphasic characteristics. The amount of MMP2 bound to TIMP2 is small for initial MMP2/TIMP2 concentration ratios larger than 1:1. Whenever the TIMP2 levels exceed the stoichiometric ratio of 1:1, the entire initial enzyme becomes trapped on the inhibitor. This "all or none" behavior is not exhibited in the case of the single isoform model. At stoichiometric excess of TIMP2, the inhibited MMP2 levels are pronounced although not total. If we now introduce collagen I into the model, we observe that upon restoration of the collagenolytic ability of MMP2, the stoichiometric criticality in the two-isoform approach is preserved. The amount of collagen cleaved at different initial MMP2/TIMP2 ratios, shown after 12 h from the initiation of the reactions (Fig. 5C) , demonstrates that the proteolysis of the substrate is negligible at large, larger than 1:1, MMP2/TIMP2 ratios and is increased at smaller values. Again this all or none behavior is not exhibited in the case of the single isoform approach.
MMP2/MT1-MMP Synergism-So far we have developed a collagen I proteolysis model by MT1-MMP and MMP2 following a modular approach. Each step of the proteolytic pathway was studied separately, and the results from the numerical experiments provided us an insight into the dynamics of the interactions of the several species comprising each particular module. By merging all of the aforementioned modules, we can study the whole pathway simultaneously. This will enable us to quantify the parallel proteolytic events that initiate from both of the studied proteases: the enzymatic synergism.
For a range of initial MT1-MMP and TIMP2 concentrations (0 -100 nM MT1-MMP and 0 -200 nM TIMP2) and in the presence of pro-MMP2 (50 nM), by taking into consideration the MT1-MMP ectodomain shedding, we can follow the dynamics and interactions of each of the formed species at different time steps as well as monitor the proteolysis of collagen I (1 M) (Fig.  6 ). Here the results are shown after 2 h (Fig. 6A ) and 36 h (Fig.  6B ) from the initiation of the reactions. In this case, to achieve the maximum pro-MMP2 activation at an intermediate time point (ϳ20 h) from the initiation of the reactions a lower shedding constant is used (k MT1 cat act,eff ϭ 0.28 ϫ 10 Ϫ3 M Ϫ1 s Ϫ1 ). The observations that have already arisen from each of the studied modules are reproducible in the composite model as well. The pro-MMP2 activation occurs at intermediate TIMP2 levels, and the maximum is almost preserved around the initial MT1-MMP/TIMP2 concentration ratio of 3:2 (Fig. 6, A, iv, and  B, iv) . Collagenolysis is enhanced at low inhibitor concentrations and is severely suppressed whenever the initial amount of the inhibitor is in stoichiometric excess (here a single MMP2⅐TIMP2 isoform approach is used), thus creating a characteristic triangular pattern in the collagenolysis contour plots (Fig. 6, A, iii, and B, iii) . For the MT1-MMP autoproteolytic behavior, we observe that the ectodomain shedding is almost negligible at sites where collagen proteolysis occurs (Fig. 6, A,  ii, and B, ii) . The shedding initiates at larger times only whenever proteolysis is completely achieved and there is available MT1-MMP to initiate its autolysis (Fig. 6, A, i, and B, i) . Furthermore it is TIMP2 that regulates the availability of the free MT1-MMP as already demonstrated in previous sections. Briefly an increase in the inhibitor level shifts the pathway from the free enzyme toward the MT1-MMP⅐TIMP2 and MT1-MMP⅐TIMP2⅐pro-MMP2 complex formation with a corresponding suppression of collagenolysis.
The question that may arise is under what conditions is the proteolysis that initiates from the active MMP2 important. Are there any proenzyme-inhibitor-activator concentration ratios that may yield synergism in collagen I proteolysis?
To answer these questions we use the theoretical model to calculate the amount of collagen that has been degraded by each of the proteolytic enzymes, MT1-MMP and MMP2, separately for the spectrum of the initial conditions used (here we use 0 -100 nM pro-MMP2 initial concentration) at different time points (Fig. 7) . For any of those initial conditions there is always MMP2 activated. The set of those initial conditions under which the collagenolysis induced from MMP2 is maximal is calculated for several time points. By plotting these maxima as a function of the initial conditions a proteolysis "phase diagram" can be constructed (Fig. 7B) . By considering the amount of proenzyme used, the interceptions of the pro-MMP2 (22) . B, by considering the inhibitor binding using the two-isoform scheme as suggested by Hutton et al. (21) , the 1:1 enzyme over inhibitor ratio is a critical point describing the availability of MMP2. For lower MMP2 than TIMP2 concentrations, the entire initial amount of the enzyme remains bound to the inhibitor and becomes available for collagen binding only when the critical ratio is exceeded. This biphasic behavior is not fully reproducible by the single MMP2⅐TIMP2 isoform scheme as suggested by Olson et al. (20) . C, the ability of MMP2 to bind TIMP2 affects its collagenolytic potential. The stoichiometric criticality of the two-isoform scheme is conserved but is not prevailing in the single isoform approach . FIG. 6. Multiple parallel activities of the MT1-MMP. A, i and ii, and B, i and ii, the free MT1-MMPs (i) and shed MT1 cat (ii) after 2 h (A) or 36 h (B) from the initiation of the biochemical reactions. These parallel activities include ectodomain shedding (ii in A and B) , pro-MMP2 activation (iii in A and B) , and collagen degradation (iv in A and B) . At sites where the MT1-MMP collagenolytic activity is effective (A, iv) the isoconcentration lines with the isochronic lines represent the above maxima for all the initial proenzyme concentrations and for a specific time point.
For the case of maximum MMP2-induced collagenolysis after 12 h, the amount of the substrate that is degraded by the other enzymes is also calculated (Fig. 7C) . For low pro-MMP2 concentration levels, the proteolysis is mostly carried out by MT1-MMP. At higher initial conditions of pro-MMP2, the collagenolytic activity of MMP2 becomes comparable with that of MT1-MMP. It is under those conditions that the MMP2/MT1-MMP synergism becomes profound (Fig. 7A) . So far, it has not been shown that the shed catalytic part of MT1-MMP, MT1 cat , has proteolytic properties. By adopting, for the particular domain, proteolytic kinetics similar to that of the full-length protease, MT1-MMP, we can calculate the amount of collagen I that could hypothetically get degraded by MT1 cat . Our calculations show that the level of proteolysis that could be achieved by this enzyme is ϳ2-5% of the total, thus almost negligible (data not shown). Another interesting observation is that for the set of conditions where the MMP2-induced collagenolysis is maximum, the total amount of collagen that is degraded is approximately constant, independent of the pro-MMP2 initial concentration and lower than the maximum possible proteolysis (here shown in Fig. 7C as the first set of lines corresponding to zero initial pro-MMP2 concentration). There is a fine tuning of the amount of the MT1-MMP used for proteolysis and for pro-MMP2 activation; the higher the activation load of the MT1-MMPs, the lower their proteolytic potential.
Conclusions-We have developed, based on existing experimental knowledge, a theoretical model for the description of the activity and regulation of the proteases MMP2 and MT1-MMP. Using a modular approach we isolated and studied separately different segments of their behavior in the context of an environment including their multifunctional inhibitor TIMP2 and collagen I, one of their multiple natural substrates.
The multiplicity of the roles of MT1-MMP is thoroughly studied experimentally. One well established phenomenon is the activation of pro-MMP2 that naturally occurs at the cell surface. We used our theoretical approach to calculate the distribution of free MT1-MMP versus the complex MT1-MMP⅐TIMP2⅐pro-MMP2, the two molecular players of the pro-MMP2 activation act. By incorporating an activation step into the kinetic scheme, we calculated those MT1-MMP and TIMP2 initial conditions where maximum pro-MMP2 activation occurs. By doing so, we demonstrated theoretically what has so far been hypothesized regarding the effects of TIMP2 on pro-MMP2 activation: low TIMP2 concentration levels are not sufficient, whereas high levels reduce the critical free MT1-MMP population responsible for activation. One of the less well studied MT1-MMP-induced phenomenon is its ectodomain shedding, the autolytic disengagement of its catalytic part. The role of TIMP2 in regulating the fate of the membrane-localized enzyme is once again vital. At small initial levels of TIMP2, the MT1-MMP either enhances its collagenolytic activity or cleaves itself thus releasing the free diffusing MT1 cat .
Once pro-MMP2 is activated, it can freely diffuse and be absorbed onto the collagen fibers or bind and get inhibited by TIMP2. Once again the role of the inhibitor is significant for the regulation of the activity of the enzymes. Finally both MMP2 and MT1-MMP can act synergistically in a well regulated process to enhance the proteolytic machinery and attenuate the restrictive barriers of the extracellular matrix. ectodomain shedding is negligible (A, ii). After 36 h and for those conditions (high MT1-MMP and low TIMP2 levels) where collagenolysis is completed (B, iv) the pro-MMP2 activation (B, iii) and ectodomain shedding (B, ii) are predominant. It is remarkable that, independently of the collagenolysis progress, the proteolytic ability of the MT1-MMP is optimized at an MT1-MMP/TIMP2 ratio greater than 1:1 thus creating the characteristic triangular pattern at the top right panels of both A, iv and B, iv. The various species concentrations are expressed as percentage of their corresponding initial concentrations.
FIG. 7. Synergism of MT1-MMP and MMP2.
A, the synergism of MT1-MMP and MMP2, presented after 12 h from the initiation of the proteolytic reactions and for 100 nM initial MT1-MMP concentration, is profound at higher TIMP2 concentration levels. B, the MMP2-induced proteolysis phase diagram. The ratios of those initial concentrations under which the collagenolysis induced from MMP2 is maximum at different times. The interceptions of the pro-MMP2 isoconcentration lines (dashed) with the isochronic lines (solid) represent the MMP2-induced proteolysis maxima for all the specific initial proenzyme concentrations. C, the amount of collagen I that is degraded by MT1-MMP and MMP2 at the points of maximum MMP-induced proteolysis after 12 h. For low pro-MMP2 concentration levels, the proteolysis is mostly carried out by MT1-MMP, while at higher pro-MMP2 concentration levels proteolytic synergism is observed. If included, the amount of collagen that could be degraded only by MT1 cat would be less than 5% of the total.
